Equity Analysis /
United States of America

US : ACADIA Pharmaceuticals Inc. - ACAD | CRL Suggests at Least 1 More Trial Needed for DRP Approval; Downgrading to Market Perform

    Daniil Gataulin
    Daniil Gataulin

    Ph.D., Sr. Res. Assoc.

    Follow
    CGS-CIMB
    5 April 2021
    Published byCGS-CIMB